MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Successful deep brain stimulation for bilateral Holmes tremor caused by progressive multifocal encephalopathy.

    T. D'Aguiar Rosa, L. Dixon, M. Khalid Yousaf, V. Holiday, A. Zemmar, J. Neimat, P. Hedera (Louisville, USA)

    Objective: To report a unique case of a patient with acquired Holmes tremor (HT) secondary to Human Immunodeficiency Virus (HIV) and progressive multifocal leukoencephalopathy (PML)…
  • 2022 International Congress

    Fatigue at different stages of parkinson’s disease

    A. Tohirjonova, м. Tohirjonov (Tashkent, Uzbekistan)

    Objective: study fatigue as a key non-motor symptom of parkinson's disease Background: Fatigue in PD refers to a state of fatigue, lack of energy, a…
  • 2022 International Congress

    Clinical and biomarker characteristics of Huntington’s Disease patients recently proposed for huntingtin-lowering clinical trial inclusion

    G. Parkin, E. Thomas, C. Snell, A. Smirnova, A. Hall, L. Bohall, E. Churchill, J. Corey-Bloom (Irvine, USA)

    Objective: We investigated plasma NfL levels, as well as clinical measures, in Huntingtin (Htt)-mutation carriers 48 years of age and under, with a CAP score…
  • 2022 International Congress

    Pons and middle cerebellar peduncle diameters are diagnostic of Multiple System Atrophy of the Cerebellar Type (MSA-C)

    C. Stephen, M. Vangel, A. Gupta, J. Macmore, J. Schmahmann (Boston, USA)

    Objective: To develop an MRI biomarker for the definitive diagnosis of Multiple System Atrophy of the Cerebellar Type (MSA-C). Background: MSA is a sporadic, adult-onset…
  • 2022 International Congress

    Jumping the Gun Sign: a sign for “Waiting Impulsivity” of progressive supranuclear palsy

    JH. Ahn, J. Youn, YE. Huh, JW. Cho (Seoul, Republic of Korea)

    Objective: We presumed that the “jumping the gun sign (JGS)” is caused by an impairment of “waiting impulsivity” rather than “stopping impulsivity”, as seen on…
  • 2022 International Congress

    Patient-specific multivariate gray matter volumetric distance to predict disease severity in Parkinson’s disease

    A. Vijayakumari, H. Fernandez, B. Walter (Cleveland, USA)

    Objective: Identifying novel biomarkers to predict disease progression is of paramount importance in patients with Parkinson’s disease (PD). In this study, we utilized Structural Magnetic…
  • 2022 International Congress

    Structural MRI prediction of freezing of gait in Parkinson’s disease after deep brain stimulation

    T. Ollivier, R. Viard, A. Rolland, R. Lopes, L. Defebvre, G. Kuchcinski, D. Devos, C. Moreau (Lille, France)

    Objective: 1) To describe the evolution of FOG in a large cohort of patients at 1 year postoperatively from bilateral STN-DBS in PD. 2) To…
  • 2022 International Congress

    Intermediate cardiac denervation in early Parkinson’s disease

    S-W. Yoo, J-S. Kim (Seoul, Republic of Korea)

    Objective: This study is aimed to evaluate the longitudinal associations between cardiac sympathetic denervation and cognitive status in Parkinson’s disease (PD). Background: There lacks an…
  • 2022 International Congress

    Developing zebrafish CRISPR/Cas9 knockout models of Parkinson’s Disease to identify novel therapeutic targets.

    J. García-Fernández, L. López-Blanch, M. Irimia, F. de Santis, J. Terriente (Badalona, Spain)

    Objective: Human patients present punctual mutations and/or small deletions in genes that have been associated with Parkinson’s disease, namely, park1, park2, park6, park7, and park8.…
  • 2022 International Congress

    Safety, Target Engagement and Effects of Bosutinib in Dementia with Lewy Bodies

    F. Pagan, Y. Torres-Yaghi, M. Hebron, R. Turner, B. Wilmarth, S. Matar, D. Ferrante, J. Ahn, C. Moussa (Washington, USA)

    Objective: To investigate the safety, biomarkers effects and determine the lowest effective dose of Bosutinibin Dementia with Lewy Bodies (DLB) Background: The effects of bosutinib,…
  • « Previous Page
  • 1
  • …
  • 131
  • 132
  • 133
  • 134
  • 135
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley